WallStreetZenWallStreetZen

NASDAQ: ANNX
Annexon Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ANNX

Based on 4 analysts offering 12 month price targets for Annexon Inc

Min Forecast
$3.00-44.55%
Avg Forecast
$12.75+135.67%
Max Forecast
$25.00+362.11%

Should I buy or sell ANNX stock?

Based on 4 analysts offering ratings for Annexon Inc.

Buy
Strong Buy
1 analysts 25%
Buy
1 analysts 25%
Hold
1 analysts 25%
Sell
1 analysts 25%
Strong Sell
0 analysts 0%
Although ANNX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ANNX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their ANNX stock forecasts and price targets.

ANNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-21
lockedlocked$00.00+00.00%2026-07-15
lockedlocked$00.00+00.00%2026-05-12
lockedlocked$00.00+00.00%2026-03-20

1 of 1

Forecast return on equity

Is ANNX forecast to generate an efficient return?

Company
146.67%
Industry
84.64%
Market
174.8%
ANNX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANNX forecast to generate an efficient return on assets?

Company
114.11%
Industry
39.55%
ANNX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANNX earnings per share forecast

What is ANNX's earnings per share in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
-$0.98
Avg 2 year Forecast
-$0.88
Avg 3 year Forecast
-$0.15

ANNX revenue forecast

What is ANNX's revenue in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$41.8M
Avg 3 year Forecast
$200.2M

ANNX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANNX$5.41$12.75+135.67%Buy
DSGN$13.99$16.67+19.14%Strong Buy
SLDB$8.39$18.71+123.05%Strong Buy
TBPH$16.93$17.50+3.37%Buy
OCS$12.68$35.00+176.03%Strong Buy
View Top Biotech Stocks

Annexon Stock Forecast FAQ

Is Annexon Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ANNX) stock is to Buy ANNX stock.

Out of 4 analysts, 1 (25%) are recommending ANNX as a Strong Buy, 1 (25%) are recommending ANNX as a Buy, 1 (25%) are recommending ANNX as a Hold, 1 (25%) are recommending ANNX as a Sell, and 0 (0%) are recommending ANNX as a Strong Sell.

If you're new to stock investing, here's how to buy Annexon stock.

What is ANNX's earnings growth forecast for 2026-2028?

(NASDAQ: ANNX) Annexon's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.81%.

Annexon's earnings in 2026 is -$198,333,000.On average, 14 Wall Street analysts forecast ANNX's earnings for 2026 to be -$160,172,465, with the lowest ANNX earnings forecast at -$183,044,883, and the highest ANNX earnings forecast at -$147,949,812. On average, 14 Wall Street analysts forecast ANNX's earnings for 2027 to be -$144,509,119, with the lowest ANNX earnings forecast at -$205,524,080, and the highest ANNX earnings forecast at -$60,556,202.

In 2028, ANNX is forecast to generate -$24,772,992 in earnings, with the lowest earnings forecast at -$142,903,462 and the highest earnings forecast at $239,128,184.

What is ANNX's revenue growth forecast for 2026-2028?

(NASDAQ: ANNX) Annexon's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.55%.

Annexon's revenue in 2026 is $0.On average, 14 Wall Street analysts forecast ANNX's revenue for 2026 to be $0, with the lowest ANNX revenue forecast at $0, and the highest ANNX revenue forecast at $0. On average, 14 Wall Street analysts forecast ANNX's revenue for 2027 to be $6,855,827,160, with the lowest ANNX revenue forecast at $982,891,385, and the highest ANNX revenue forecast at $18,063,639,815.

In 2028, ANNX is forecast to generate $32,796,360,831 in revenue, with the lowest revenue forecast at $18,096,408,322 and the highest revenue forecast at $73,114,732,583.

What is ANNX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ANNX) forecast ROA is 114.11%, which is higher than the forecast US Biotechnology industry average of 39.55%.

What is ANNX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ANNX price target, the average ANNX price target is $12.75, with the highest ANNX stock price forecast at $25.00 and the lowest ANNX stock price forecast at $3.00.

On average, Wall Street analysts predict that Annexon's share price could reach $12.75 by Jul 21, 2027. The average Annexon stock price prediction forecasts a potential upside of 135.67% from the current ANNX share price of $5.41.

What is ANNX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ANNX) Annexon's current Earnings Per Share (EPS) is -$1.20. On average, analysts forecast that ANNX's EPS will be -$0.98 for 2026, with the lowest EPS forecast at -$1.12, and the highest EPS forecast at -$0.90. On average, analysts forecast that ANNX's EPS will be -$0.88 for 2027, with the lowest EPS forecast at -$1.25, and the highest EPS forecast at -$0.37. In 2028, ANNX's EPS is forecast to hit -$0.15 (min: -$0.87, max: $1.46).

What is ANNX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ANNX) forecast ROE is 146.67%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.